Cutaneous adverse reactions specific to epidermal growth factor receptor inhibitors

Classical antineoplastic therapy is encumbered by extensively studied adverse reactions, most often of systemic nature. The emergence of new generations of anticancer treatments, including epidermal growth factor receptor inhibitors, besides improving the response to treatment and the survival rate,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Med Life
Hlavní autoři: Lupu, I, Voiculescu, VM, Bacalbasa, N, Prie, BE, Cojocaru, I, Giurcaneanu, C
Médium: Artigo
Jazyk:Inglês
Vydáno: Carol Davila University Press 2015
Témata:
General Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4564034/
https://ncbi.nlm.nih.gov/pubmed/26361513
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky